Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Multiple Sclerosis

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    April 2008
  1. YOUNG EA , Fowler CD, Kidd GJ, Chang A, et al
    Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.
    Ann Neurol. 2008;63:428-35.
    PubMed     Related articles    Abstract available


    March 2008
  2. KHALEELI Z , Ciccarelli O, Manfredonia F, Barkhof F, et al
    Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study.
    Ann Neurol. 2008;.
    PubMed     Related articles    Abstract available


  3. WAXMAN SG
    Axonal dysfunction in chronic multiple sclerosis: Meltdown in the membrane.
    Ann Neurol. 2008;.
    PubMed     Related articles   


  4. BAR-OR A , Calabresi PA, Arnlod D, Markowitz C, et al
    Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
    Ann Neurol. 2008;63:395-400.
    PubMed     Related articles    Abstract available


  5. GILDEN DH
    Is varicella zoster virus really involved in the pathogenesis of multiple sclerosis?
    Ann Neurol. 2008;63:269-71.
    PubMed     Related articles   


  6. GHASSEMI R , Antel SB, Narayanan S, Francis SJ, et al
    Lesion distribution in children with clinically isolated syndromes.
    Ann Neurol. 2008;63:401-5.
    PubMed     Related articles    Abstract available


    February 2008
  7. SOTELO J , Martinez-Palomo A, Ordonez G, Pineda B, et al
    Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis.
    Ann Neurol. 2008;.
    PubMed     Related articles    Abstract available


  8. CHEN JT , Collins DL, Atkins HL, Freedman MS, et al
    Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions.
    Ann Neurol. 2008;.
    PubMed     Related articles    Abstract available


    January 2008
  9. RAINE CS
    Multiple sclerosis: Classification revisited reveals homogeneity and recapitulation.
    Ann Neurol. 2008;63:1-3.
    PubMed     Related articles   


  10. BREIJ EC , Brink BP, Veerhuis R, van den Berg C, et al
    Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Ann Neurol. 2008;63:16-25.
    PubMed     Related articles    Abstract available


  11. BANWELL B , Bar-Or A, Cheung R, Kennedy J, et al
    Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
    Ann Neurol. 2008;63:98-111.
    PubMed     Related articles    Abstract available


    October 2007
  12. HEMMER B , Hartung HP
    Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Ann Neurol. 2007;62:314-326.
    PubMed     Related articles    Abstract available


  13. DAL BIANCO A , Bradl M, Frischer J, Kutzelnigg A, et al
    Multiple sclerosis and Alzheimer's disease.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  14. TANZER J
    Estrogen effect in multiple sclerosis more nuanced than described.
    Ann Neurol. 2007;.
    PubMed     Related articles   


    September 2007
  15. STEINER I , Sriram S
    The "one virus, one disease" model of multiple sclerosis is too constraining.
    Ann Neurol. 2007;.
    PubMed     Related articles   


  16. FILIPPI M , Hartung HP
    What do we really see when we look at magnetic resonance images?
    Ann Neurol. 2007;62:207-209.
    PubMed     Related articles   


  17. KALSI V , Gonzales G, Popat R, Apostolidis A, et al
    Botulinum injections for the treatment of bladder symptoms of multiple sclerosis.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  18. KONING N , Bo L, Hoek RM, Huitinga I, et al
    Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  19. DORSEY ER , Holloway RG
    Quality of life in epilepsy, multiple sclerosis, and beyond.
    Ann Neurol. 2007;.
    PubMed     Related articles   


    August 2007
  20. RUDICK RA , Miller D, Hass S, Hutchinson M, et al
    Health-related quality of life in multiple sclerosis: effects of natalizumab.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  21. GOUT O
    Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
    Ann Neurol. 2007;.
    PubMed     Related articles   


  22. KOCH M , Mostert J, De Keyser J, Tremlett H, et al
    Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis.
    Ann Neurol. 2007;.
    PubMed     Related articles   


    May 2007
  23. ASCHERIO A , Munger KL
    Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


    April 2007
  24. LIPTON HL , Liang Z, Hertzler S, Son KN, et al
    A specific viral cause of multiple sclerosis: One virus, one disease.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  25. ASCHERIO A , Munger KL
    Environmental risk factors for multiple sclerosis. Part I: The role of infection.
    Ann Neurol. 2007;61:288-299.
    PubMed     Related articles    Abstract available


  26. RUDICK RA , Cutter G
    Interferon-beta for multiple sclerosis: Long-term benefits?
    Ann Neurol. 2007;61:283-285.
    PubMed     Related articles   


  27. TROJANO M , Pellegrini F, Fuiani A, Paolicelli D, et al
    New natural history of interferon-beta-treated relapsing multiple sclerosis.
    Ann Neurol. 2007;61:300-306.
    PubMed     Related articles    Abstract available


  28. FISHER E , Chang A, Fox RJ, Tkach JA, et al
    Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  29. FLEMING J , Fabry Z
    The hygiene hypothesis and multiple sclerosis.
    Ann Neurol. 2007;61:85-89.
    PubMed     Related articles   


    January 2007
  30. WOLINSKY JS , Narayana PA, O'connor P, Coyle PK, et al
    Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial.
    Ann Neurol. 2007;61:14-24.
    PubMed     Related articles    Abstract available


  31. YEO TW , De Jager PL, Gregory SG, Barcellos LF, et al
    A second major histocompatibility complex susceptibility locus for multiple sclerosis.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  32. CORREALE J , Farez M
    Association between parasite infection and immune responses in multiple sclerosis.
    Ann Neurol. 2007;.
    PubMed     Related articles    Abstract available


  33. THOMPSON AJ
    Promises, promises...
    Ann Neurol. 2007;61:1-2.
    PubMed     Related articles   


    November 2006
  34. HAUSER SL , Johnston SC
    Recombinant therapeutics: from bench to bedside (if your health plan concurs).
    Ann Neurol. 2006;60:10A-11A.
    PubMed     Related articles    Abstract available


    October 2006
  35. LIPTON HL
    B lineage cells in inflammatory central nervous system.
    Ann Neurol. 2006;60:486-7.
    PubMed     Related articles   


    September 2006
  36. DEL BOCCIO P , Pieragostino D, Lugaresi A, Di Ioia M, et al
    Cleavage of cystatin C is not associated with multiple sclerosis.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


  37. NAKASHIMA I , Fujinoki M, Fujihara K, Kawamura T, et al
    Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  38. HANSSON SF , Hviid Simonsen A, Zetterberg H, Andersen O, et al
    Cystatin C in cerebrospinal fluid and multiple sclerosis.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


    July 2006
  39. NAKASHIMA I , Fujihara K, Fujinoki M, Kawamura T, et al
    Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.
    Ann Neurol. 2006;.
    PubMed     Related articles   


  40. STUVE O
    Statins and the blood-brain barrier: plugging the holes.
    Ann Neurol. 2006;60:1-2.
    PubMed     Related articles   


    June 2006
  41. STEINMAN L , Zamvil SS
    How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.
    Ann Neurol. 2006;60:12-21.
    PubMed     Related articles    Abstract available


  42. RUDICK RA , Lee JC, Simon J, Fisher E, et al
    Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


  43. MORENO B , Hevia H, Santamaria M, Sepulcre J, et al
    Methylthioadenosine reverses brain autoimmune disease.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


  44. MEINL E , Krumbholz M, Hohlfeld R
    B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.
    Ann Neurol. 2006;59:880-92.
    PubMed     Related articles    Abstract available


    May 2006
  45. IFERGAN I , Wosik K, Cayrol R, Kebir H, et al
    Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosis.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


  46. ISLAM T , Gauderman WJ, Cozen W, Hamilton AS, et al
    Differential twin concordance for multiple sclerosis by latitude of birthplace.
    Ann Neurol. 2006;.
    PubMed     Related articles    Abstract available


  47. PANITCH HS , Thisted RA, Smith RA, Wynn DR, et al
    Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
    Ann Neurol. 2006;59:780-7.
    PubMed     Related articles    Abstract available


  48. NIINO M , Bodner C, Simard ML, Alatab S, et al
    Natalizumab effects on immune cell responses in multiple sclerosis.
    Ann Neurol. 2006;59:748-54.
    PubMed     Related articles    Abstract available


  49. STUVE O , Marra CM, Jerome KR, Cook L, et al
    Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Ann Neurol. 2006;59:743-7.
    PubMed     Related articles    Abstract available


  50. POLMAN CH , Reingold SC, Weinshenker BG
    Reply.
    Ann Neurol. 2006;59:871.
    PubMed     Related articles   


  51. HAUSER SL , Weiner HL
    Natalizumab: immune effects and implications for therapy.
    Ann Neurol. 2006;59:731-2.
    PubMed     Related articles   


    April 2006
  52. POSER CM
    Revisions to the 2001 McDonald diagnostic criteria.
    Ann Neurol. 2006;59:727-8.
    PubMed     Related articles   


    March 2006
  53. GOODIN DS
    Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment?
    Ann Neurol. 2006;59:597-605.
    PubMed     Related articles    Abstract available


  54. HAUSER SL
    Multiple sclerosis: Tip of the iceberg?
    Ann Neurol. 2006;59:11-12.
    PubMed     Related articles   


  55. WEINSHENKER BG , Wingerchuk DM, Vukusic S, Linbo L, et al
    Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.
    Ann Neurol. 2006;59:566-9.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Bernd Sebastian Kamps website.

   Design: